US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lyell Immunopharma, Inc.

11.02

+0.26002.42%

Volume:17.14K

Turnover:190.59K

Market Cap:211.71M

PE:-0.45

High:11.47

Open:10.77

Low:10.76

Close:10.76

52wk High:32.40

52wk Low:7.65

Shares:19.21M

Float Shares:13.11M

Volume Ratio:0.86

T/O Rate:0.13%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-24.6251

EPS(LYR):-26.2348

ROE:-76.59%

ROA:-25.39%

PB:0.71

PE(LYR):-0.42

Loading ...

Overview Company News Filings

Lyell Immunopharma (LYEL) Receives a Sell from Bank of America Securities

Lyell Immunopharma's Chief Scientific Officer Gary K. Lee Reports Disposal of Common Shares

Analysts Offer Insights on Healthcare Companies: Catalyst Pharma (CPRX), BioAge Labs, Inc. (BIOA) and Lyell Immunopharma (LYEL)

CFO Charles W. Newton Reports Disposal of Lyell Immunopharma Common Shares

Lyell Immunopharma trading resumes

Lyell Immunopharma Reports Q2 2025 Net Loss of $42.7M, Decrease from $45.8M in Q2 2024

Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025

Lyell Immunopharma Inc expected to post a loss of $3.58 a share - Earnings Preview

Lyell Immunopharma Inc. Files Initial Statement of Beneficial Ownership for ARCH Venture Fund XIII, L.P

Lyell Immunopharma Initiates Phase 3 Clinical Trial for LYL314 in Relapsed or Refractory Large B-Cell Lymphoma

Lyell Immunopharma Announces Up to $100 Million Equity Private Placement to Fund Clinical Trials and Corporate Initiatives

Lyell Immunopharma Announces up to $100 Million Equity Private Placement

THOMSON REUTERS

Lyell Immunopharma Inc - Proceeds to Fund Two Pivotal-Stage Trials of Lyl314

THOMSON REUTERS

Lyell Immunopharma files to sell 625,000 shares of common stock for holders

Lyell Immunopharma Inc. Completes Issuance of 625,000 Equity Milestone Shares Following ImmPACT Acquisition

Lyell Immunopharma Is Maintained at Neutral by HC Wainwright & Co.

Lyell Immunopharma Inc. to Participate in H.C. Wainwright "HCW@Home" Series for Discussion on Innovative CAR T-Cell Therapies

Morgan Stanley Sticks to Its Hold Rating for Lyell Immunopharma (LYEL)

BUZZ-U.S. STOCKS ON THE MOVE-Red Cat, Nvidia Corp, Redwire

BUZZ-U.S. STOCKS ON THE MOVE-Verve Therapeutics, Lyell Immunopharma, Energy companies

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LYEL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LYEL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LYEL\",,,,,undefined,":{"symbol":"LYEL","market":"US","secType":"STK","nameCN":"Lyell Immunopharma, Inc.","latestPrice":11.02,"timestamp":1756147033951,"preClose":10.76,"halted":0,"volume":17142,"delay":0,"floatShares":13109121,"shares":19211200,"eps":-24.625135,"marketStatus":"Trading","change":0.26,"latestTime":"08-25 14:37:43 EDT","open":10.77,"high":11.47,"low":10.76,"amount":190592.418474,"amplitude":0.065985,"askPrice":11.07,"askSize":5,"bidPrice":10.98,"bidSize":39,"shortable":3,"etf":0,"ttmEps":-24.625135,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1756152000000},"marketStatusCode":2,"adr":0,"listingDate":1623902400000,"exchange":"NASDAQ","adjPreClose":10.76,"postHourTrading":{"tag":"盘后","latestPrice":10.76,"preClose":10.76,"latestTime":"16:10 EDT","volume":21,"amount":225.96,"timestamp":1755893404467},"volumeRatio":0.859928,"impliedVol":0.2653,"impliedVolPercentile":0.0803},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LYEL\",,,,,undefined,":{"symbol":"LYEL","floatShares":13109121,"roa":"-25.39%","roe":"-76.59%","lyrEps":-26.234817,"volumeRatio":0.859928,"shares":19211200,"dividePrice":0,"high":11.47,"amplitude":0.065985,"preClose":10.76,"low":10.76,"week52Low":7.65,"pbRate":"0.71","psRate":"3528.46","week52High":32.4,"institutionHeld":0,"latestPrice":11.02,"committee":0.772727,"eps":-24.625135,"divideRate":0,"volume":17142,"delay":0,"ttmEps":-24.625135,"open":10.77,"prevYearClose":12.8,"prevWeekClose":10.76,"prevMonthClose":11.81,"prevQuarterClose":8.84,"fiveDayClose":10.885,"twentyDayClose":13.73,"sixtyDayClose":8.032},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LYEL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-12","symbol":"LYEL","fiscalQuarterEnding":"2025/06","expectedEps":-3.8,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-2.89},{"market":"US","date":"2025-06-02","symbol":"LYEL","defaultRemindTime":1748871000000,"type":"split","dateTimestamp":1748836800000,"forFactor":20,"toFactor":1,"ratio":20},{"market":"US","date":"2025-05-13","symbol":"LYEL","fiscalQuarterEnding":"2025/03","expectedEps":-0.19,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2021-08-12","symbol":"LYEL","fiscalQuarterEnding":"2021/06","expectedEps":-1.54,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-1.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LYEL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LYEL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":0.5,"sell":0.5,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.5,"analysts":2,"updateTime":1730347200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LYEL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LYEL","date":"2025-08-22","current":-0.617384,"percent":0.893555,"low":-22.356321,"twenty":-7.230435,"median":-2.981027,"eighty":-1.424546,"high":-0.344317,"avg":-4.840771,"sd":4.832186,"marketCap":204599301},"quantilePoints":[{"date":"2021-06-18","current":-16.694562,"twenty":-17.926867,"median":-17.666247,"eighty":-17.121201,"marketCap":3844340254},{"date":"2021-06-25","current":-16.478151,"twenty":-17.614123,"median":-17.106773,"eighty":-16.61212,"marketCap":3794506214},{"date":"2021-07-02","current":-16.519372,"twenty":-17.263414,"median":-16.936736,"eighty":-16.511128,"marketCap":3803998412},{"date":"2021-07-09","current":-16.364793,"twenty":-17.143872,"median":-16.715173,"eighty":-16.410136,"marketCap":3768402669},{"date":"2021-07-16","current":-17.426237,"twenty":-17.174788,"median":-16.735783,"eighty":-16.482273,"marketCap":4012826772},{"date":"2021-07-23","current":-14.870526,"twenty":-17.174788,"median":-16.725478,"eighty":-16.253496,"marketCap":3424310486},{"date":"2021-07-30","current":-14.942663,"twenty":-17.143872,"median":-16.560593,"eighty":-15.769148,"marketCap":3440921833},{"date":"2021-08-06","current":-16.117466,"twenty":-17.090285,"median":-16.509067,"eighty":-15.769148,"marketCap":3711449480},{"date":"2021-08-13","current":-18.445521,"twenty":-17.143872,"median":-16.498762,"eighty":-15.358997,"marketCap":3545487430},{"date":"2021-08-20","current":-18.856529,"twenty":-17.417993,"median":-16.627578,"eighty":-15.57953,"marketCap":3624488838},{"date":"2021-08-27","current":-20.214099,"twenty":-17.926867,"median":-16.735783,"eighty":-15.769148,"marketCap":3885432883},{"date":"2021-09-03","current":-20.525469,"twenty":-18.490358,"median":-16.802768,"eighty":-15.903116,"marketCap":3945282434},{"date":"2021-09-10","current":-22.356321,"twenty":-19.232663,"median":-17.003721,"eighty":-15.991741,"marketCap":4297197797},{"date":"2021-09-17","current":-14.709089,"twenty":-19.232663,"median":-16.952194,"eighty":-15.876323,"marketCap":2827292812},{"date":"2021-09-24","current":-15.294463,"twenty":-19.005986,"median":-16.777005,"eighty":-15.276839,"marketCap":2939809969},{"date":"2021-10-01","current":-16.552396,"twenty":-18.789273,"median":-16.78731,"eighty":-15.333339,"marketCap":3181602157},{"date":"2021-10-08","current":-16.116478,"twenty":-18.505304,"median":-16.725478,"eighty":-15.276839,"marketCap":3097812785},{"date":"2021-10-15","current":-16.539941,"twenty":-18.44303,"median":-16.694562,"eighty":-15.276839,"marketCap":3179208175},{"date":"2021-10-22","current":-17.175134,"twenty":-18.41563,"median":-16.725478,"eighty":-15.333339,"marketCap":3301301260},{"date":"2021-10-29","current":-17.361956,"twenty":-18.41563,"median":-16.78731,"eighty":-15.492314,"marketCap":3337210991},{"date":"2021-11-05","current":-17.212499,"twenty":-18.44303,"median":-16.889297,"eighty":-15.548067,"marketCap":3308483206},{"date":"2021-11-12","current":-13.33676,"twenty":-18.41563,"median":-16.78731,"eighty":-15.276839,"marketCap":2738970350},{"date":"2021-11-19","current":-12.657627,"twenty":-18.330937,"median":-16.725478,"eighty":-15.027931,"marketCap":2599496882},{"date":"2021-11-26","current":-10.90125,"twenty":-18.271154,"median":-16.627578,"eighty":-14.942663,"marketCap":2238789637},{"date":"2021-12-03","current":-10.409464,"twenty":-18.134152,"median":-16.539941,"eighty":-14.709089,"marketCap":2137791608},{"date":"2021-12-10","current":-10.948086,"twenty":-18.109242,"median":-16.493609,"eighty":-14.3479,"marketCap":2248408496},{"date":"2021-12-17","current":-9.765459,"twenty":-18.071878,"median":-16.415393,"eighty":-13.737616,"marketCap":2005532284},{"date":"2021-12-23","current":-9.613239,"twenty":-18.012095,"median":-16.364793,"eighty":-12.985484,"marketCap":1974270990},{"date":"2021-12-31","current":-9.062908,"twenty":-17.940923,"median":-16.245376,"eighty":-12.198627,"marketCap":1861249386},{"date":"2022-01-07","current":-7.470459,"twenty":-17.926867,"median":-16.141388,"eighty":-11.395378,"marketCap":1534208150},{"date":"2022-01-14","current":-7.072347,"twenty":-17.903382,"median":-16.080903,"eighty":-10.997265,"marketCap":1452447841},{"date":"2022-01-21","current":-6.123903,"twenty":-17.830255,"median":-16.014551,"eighty":-10.929352,"marketCap":1257665929},{"date":"2022-01-28","current":-6.147321,"twenty":-17.680798,"median":-15.983497,"eighty":-10.514847,"marketCap":1262475359},{"date":"2022-02-04","current":-6.627398,"twenty":-17.596106,"median":-15.610877,"eighty":-9.704571,"marketCap":1361068673},{"date":"2022-02-11","current":-7.072347,"twenty":-17.556251,"median":-15.294463,"eighty":-9.011387,"marketCap":1452447841},{"date":"2022-02-18","current":-7.013801,"twenty":-17.470271,"median":-15.182102,"eighty":-8.728025,"marketCap":1440424267},{"date":"2022-02-25","current":-8.102755,"twenty":-17.425434,"median":-15.057823,"eighty":-8.163643,"marketCap":1664062759},{"date":"2022-03-04","current":-7.634387,"twenty":-17.416789,"median":-14.958184,"eighty":-7.964586,"marketCap":1567874160},{"date":"2022-03-11","current":-7.669515,"twenty":-17.388159,"median":-14.860221,"eighty":-7.915408,"marketCap":1575088305},{"date":"2022-03-18","current":-7.013801,"twenty":-17.351992,"median":-14.709089,"eighty":-7.723377,"marketCap":1440424267},{"date":"2022-03-25","current":-5.971683,"twenty":-17.3221,"median":-14.403329,"eighty":-7.58755,"marketCap":1226404634},{"date":"2022-04-01","current":-5.20082,"twenty":-17.2947,"median":-14.061441,"eighty":-7.470459,"marketCap":1301343937},{"date":"2022-04-08","current":-5.288147,"twenty":-17.257336,"median":-13.830028,"eighty":-7.346342,"marketCap":1323194861},{"date":"2022-04-14","current":-5.229929,"twenty":-17.211964,"median":-13.518506,"eighty":-7.16602,"marketCap":1308627578},{"date":"2022-04-22","current":-5.045571,"twenty":-17.203643,"median":-12.938648,"eighty":-7.018485,"marketCap":1262497849},{"date":"2022-04-29","current":-4.97765,"twenty":-17.178155,"median":-12.487844,"eighty":-6.955255,"marketCap":1245502686},{"date":"2022-05-06","current":-5.152305,"twenty":-17.173828,"median":-11.627219,"eighty":-6.641449,"marketCap":1289204534},{"date":"2022-05-13","current":-3.729604,"twenty":-17.156239,"median":-11.381327,"eighty":-6.524357,"marketCap":982079216},{"date":"2022-05-20","current":-3.841772,"twenty":-17.098529,"median":-11.135433,"eighty":-6.360429,"marketCap":1011615433},{"date":"2022-05-27","current":-4.056762,"twenty":-17.063491,"median":-10.953941,"eighty":-6.039597,"marketCap":1068226516},{"date":"2022-06-03","current":-4.711078,"twenty":-17.055247,"median":-10.924668,"eighty":-5.971683,"marketCap":1240521115},{"date":"2022-06-10","current":-4.767162,"twenty":-16.952194,"median":-10.74903,"eighty":-5.501614,"marketCap":1255289224},{"date":"2022-06-17","current":-5.103668,"twenty":-16.826401,"median":-10.444591,"eighty":-5.278444,"marketCap":1343897875},{"date":"2022-06-24","current":-6.225353,"twenty":-16.81986,"median":-9.993788,"eighty":-5.286206,"marketCap":1639260045},{"date":"2022-07-01","current":-5.599079,"twenty":-16.793493,"median":-9.191709,"eighty":-5.303672,"marketCap":1474349500},{"date":"2022-07-08","current":-6.281438,"twenty":-16.774943,"median":-9.016071,"eighty":-5.331041,"marketCap":1654028154},{"date":"2022-07-15","current":-5.514953,"twenty":-16.748149,"median":-8.822869,"eighty":-5.314216,"marketCap":1452197337},{"date":"2022-07-22","current":-5.3467,"twenty":-16.723417,"median":-8.664796,"eighty":-5.314216,"marketCap":1407893012},{"date":"2022-07-29","current":-5.206489,"twenty":-16.702806,"median":-8.301811,"eighty":-5.299791,"marketCap":1370972740},{"date":"2022-08-05","current":-7.600529,"twenty":-16.614181,"median":-8.044209,"eighty":-5.299791,"marketCap":1801690265},{"date":"2022-08-12","current":-7.642348,"twenty":-16.555675,"median":-7.991734,"eighty":-5.314216,"marketCap":1811603279},{"date":"2022-08-19","current":-7.360072,"twenty":-16.544923,"median":-7.950535,"eighty":-5.335483,"marketCap":1744690435},{"date":"2022-08-26","current":-6.575974,"twenty":-16.5276,"median":-7.950535,"eighty":-5.3467,"marketCap":1558821426},{"date":"2022-09-02","current":-7.192798,"twenty":-16.507006,"median":-7.89199,"eighty":-5.375608,"marketCap":1705038380},{"date":"2022-09-09","current":-7.935078,"twenty":-16.49464,"median":-7.88028,"eighty":-5.416736,"marketCap":1880994376},{"date":"2022-09-16","current":-7.516892,"twenty":-16.484334,"median":-7.897852,"eighty":-5.449521,"marketCap":1781864237},{"date":"2022-09-23","current":-6.670066,"twenty":-16.453048,"median":-7.861895,"eighty":-5.45326,"marketCap":1581125707},{"date":"2022-09-30","current":-7.663257,"twenty":-16.400447,"median":-7.848297,"eighty":-5.462607,"marketCap":1816559786},{"date":"2022-10-07","current":-7.391436,"twenty":-16.372735,"median":-7.851441,"eighty":-5.468216,"marketCap":1752125196},{"date":"2022-10-14","current":-6.83734,"twenty":-16.35016,"median":-7.81485,"eighty":-5.468216,"marketCap":1620777762},{"date":"2022-10-21","current":-6.847795,"twenty":-16.313264,"median":-7.751479,"eighty":-5.477563,"marketCap":1623256016},{"date":"2022-10-28","current":-6.38779,"twenty":-16.25447,"median":-7.704859,"eighty":-5.495596,"marketCap":1514212864},{"date":"2022-11-04","current":-5.93824,"twenty":-16.191664,"median":-7.669515,"eighty":-5.50695,"marketCap":1407647965},{"date":"2022-11-11","current":-4.370461,"twenty":-16.164134,"median":-7.652802,"eighty":-5.468216,"marketCap":1129445090},{"date":"2022-11-18","current":-4.235391,"twenty":-16.131819,"median":-7.634387,"eighty":-5.449521,"marketCap":1094539502},{"date":"2022-11-25","current":-4.013492,"twenty":-16.117268,"median":-7.600529,"eighty":-5.3467,"marketCap":1037194608},{"date":"2022-12-02","current":-3.88807,"twenty":-16.102248,"median":-7.558277,"eighty":-5.287232,"marketCap":1004782276},{"date":"2022-12-09","current":-3.38156,"twenty":-16.041207,"median":-7.516892,"eighty":-5.259745,"marketCap":873886322},{"date":"2022-12-16","current":-3.116245,"twenty":-16.020651,"median":-7.489702,"eighty":-5.234588,"marketCap":805321775},{"date":"2022-12-23","current":-2.942584,"twenty":-16.001894,"median":-7.470459,"eighty":-5.20082,"marketCap":760443162},{"date":"2022-12-30","current":-3.347792,"twenty":-15.991931,"median":-7.407118,"eighty":-5.178447,"marketCap":865159925},{"date":"2023-01-06","current":-3.154836,"twenty":-15.985184,"median":-7.391436,"eighty":-5.132899,"marketCap":815294800},{"date":"2023-01-13","current":-3.116245,"twenty":-15.876323,"median":-7.35672,"eighty":-5.045571,"marketCap":805321775},{"date":"2023-01-20","current":-2.884697,"twenty":-15.769148,"median":-7.319501,"eighty":-5.004818,"marketCap":745483624},{"date":"2023-01-27","current":-3.222371,"twenty":-15.58994,"median":-7.255526,"eighty":-4.957491,"marketCap":832747594},{"date":"2023-02-03","current":-3.280258,"twenty":-15.495784,"median":-7.203252,"eighty":-4.852942,"marketCap":847707131},{"date":"2023-02-10","current":-2.759276,"twenty":-15.372215,"median":-7.16602,"eighty":-4.658733,"marketCap":713071293},{"date":"2023-02-17","current":-2.51808,"twenty":-15.281245,"median":-7.127136,"eighty":-4.40097,"marketCap":650739886},{"date":"2023-02-24","current":-2.054985,"twenty":-15.24139,"median":-7.072347,"eighty":-4.297137,"marketCap":531063585},{"date":"2023-03-03","current":-3.026095,"twenty":-15.184647,"median":-7.037219,"eighty":-4.234774,"marketCap":554132528},{"date":"2023-03-10","current":-2.712581,"twenty":-15.144685,"median":-7.009208,"eighty":-4.144702,"marketCap":496722401},{"date":"2023-03-17","current":-2.903416,"twenty":-15.067786,"median":-7.002092,"eighty":-4.0308,"marketCap":531667696},{"date":"2023-03-24","current":-2.739843,"twenty":-15.002478,"median":-6.947944,"eighty":-3.941641,"marketCap":501714586},{"date":"2023-03-31","current":-3.21693,"twenty":-14.979788,"median":-6.847795,"eighty":-3.877116,"marketCap":589077822},{"date":"2023-04-06","current":-3.503182,"twenty":-14.95508,"median":-6.791326,"eighty":-3.841772,"marketCap":641495764},{"date":"2023-04-14","current":-3.775804,"twenty":-14.928236,"median":-6.698816,"eighty":-3.793887,"marketCap":691417614},{"date":"2023-04-21","current":-3.053357,"twenty":-14.866404,"median":-6.650816,"eighty":-3.755799,"marketCap":559124713},{"date":"2023-04-28","current":-2.658057,"twenty":-14.849916,"median":-6.633253,"eighty":-3.642559,"marketCap":486738031},{"date":"2023-05-05","current":-3.298717,"twenty":-14.821751,"median":-6.575974,"eighty":-3.508635,"marketCap":604054377},{"date":"2023-05-12","current":-3.457401,"twenty":-14.671725,"median":-6.54314,"eighty":-3.473214,"marketCap":629015302},{"date":"2023-05-19","current":-3.457401,"twenty":-14.499848,"median":-6.38779,"eighty":-3.464474,"marketCap":629015302},{"date":"2023-05-26","current":-3.896436,"twenty":-14.407436,"median":-6.36768,"eighty":-3.473214,"marketCap":708890261},{"date":"2023-06-02","current":-4.568708,"twenty":-14.396483,"median":-6.357152,"eighty":-3.473214,"marketCap":831198792},{"date":"2023-06-09","current":-4.225712,"twenty":-14.3479,"median":-6.281438,"eighty":-3.503182,"marketCap":768796480},{"date":"2023-06-16","current":-5.29586,"twenty":-14.061441,"median":-6.257519,"eighty":-3.503182,"marketCap":963491693},{"date":"2023-06-23","current":-4.513829,"twenty":-14.001658,"median":-6.228162,"eighty":-3.524992,"marketCap":821214422},{"date":"2023-06-30","current":-4.294311,"twenty":-13.948149,"median":-6.173469,"eighty":-3.546802,"marketCap":781276943},{"date":"2023-07-07","current":-3.930735,"twenty":-13.84851,"median":-6.1421,"eighty":-3.566976,"marketCap":715130492},{"date":"2023-07-14","current":-4.294311,"twenty":-13.72267,"median":-6.113185,"eighty":-3.59924,"marketCap":781276943},{"date":"2023-07-21","current":-4.253152,"twenty":-13.554855,"median":-6.089817,"eighty":-3.631866,"marketCap":773788665},{"date":"2023-07-27","current":-4.253152,"twenty":-13.33676,"median":-6.029058,"eighty":-3.639493,"marketCap":773788665},{"date":"2023-08-03","current":-3.622039,"twenty":-13.065106,"median":-5.995102,"eighty":-3.636951,"marketCap":658968412},{"date":"2023-08-11","current":-2.767887,"twenty":-12.950357,"median":-5.958308,"eighty":-3.576245,"marketCap":579872363},{"date":"2023-08-18","current":-2.684012,"twenty":-12.835607,"median":-5.924847,"eighty":-3.497188,"marketCap":562300473},{"date":"2023-08-25","current":-2.67203,"twenty":-12.688071,"median":-5.837903,"eighty":-3.457401,"marketCap":559790203},{"date":"2023-09-01","current":-2.863745,"twenty":-12.385974,"median":-5.708238,"eighty":-3.438793,"marketCap":599954522},{"date":"2023-09-08","current":-2.34851,"twenty":-11.95976,"median":-5.599079,"eighty":-3.385905,"marketCap":492012914},{"date":"2023-09-15","current":-2.090893,"twenty":-11.683423,"median":-5.5243,"eighty":-3.342883,"marketCap":438042109},{"date":"2023-09-22","current":-1.773365,"twenty":-11.566331,"median":-5.496599,"eighty":-3.255097,"marketCap":371519955},{"date":"2023-09-29","current":-1.881205,"twenty":-11.446898,"median":-5.468216,"eighty":-3.219106,"marketCap":394112385},{"date":"2023-10-06","current":-1.785347,"twenty":-11.38601,"median":-5.454194,"eighty":-3.197376,"marketCap":374030225},{"date":"2023-10-13","current":-1.869223,"twenty":-11.287653,"median":-5.39488,"eighty":-3.168343,"marketCap":391602115},{"date":"2023-10-20","current":-1.893187,"twenty":-11.163535,"median":-5.332679,"eighty":-3.158301,"marketCap":396622655},{"date":"2023-10-27","current":-1.953098,"twenty":-11.1448,"median":-5.313106,"eighty":-3.154836,"marketCap":409174005},{"date":"2023-11-03","current":-2.396439,"twenty":-11.032392,"median":-5.288147,"eighty":-3.144199,"marketCap":502053994},{"date":"2023-11-10","current":-2.901609,"twenty":-10.969163,"median":-5.278444,"eighty":-3.116245,"marketCap":551593039},{"date":"2023-11-17","current":-2.47763,"twenty":-10.950428,"median":-5.259038,"eighty":-3.07552,"marketCap":470994970},{"date":"2023-11-24","current":-2.225892,"twenty":-10.948086,"median":-5.259038,"eighty":-3.034274,"marketCap":423139866},{"date":"2023-12-01","current":-2.292139,"twenty":-10.919984,"median":-5.220226,"eighty":-2.985202,"marketCap":435733314},{"date":"2023-12-08","current":-2.570375,"twenty":-10.859097,"median":-5.20082,"eighty":-2.966092,"marketCap":488625797},{"date":"2023-12-15","current":-2.67637,"twenty":-10.781816,"median":-5.191971,"eighty":-2.932936,"marketCap":508775315},{"date":"2023-12-22","current":-2.649872,"twenty":-10.622571,"median":-5.162008,"eighty":-2.925226,"marketCap":503737936},{"date":"2023-12-29","current":-2.795615,"twenty":-10.526556,"median":-5.142602,"eighty":-2.903531,"marketCap":531443522},{"date":"2024-01-05","current":-2.636622,"twenty":-10.491428,"median":-5.132899,"eighty":-2.892415,"marketCap":501219246},{"date":"2024-01-12","current":-2.914859,"twenty":-10.423515,"median":-5.074619,"eighty":-2.876069,"marketCap":554111729},{"date":"2024-01-19","current":-2.610123,"twenty":-10.297056,"median":-5.040719,"eighty":-2.870527,"marketCap":496181866},{"date":"2024-01-26","current":-2.769116,"twenty":-9.948122,"median":-4.987353,"eighty":-2.82681,"marketCap":526406143},{"date":"2024-02-02","current":-2.451131,"twenty":-9.674127,"median":-4.970553,"eighty":-2.813035,"marketCap":465957590},{"date":"2024-02-09","current":-2.26564,"twenty":-9.360321,"median":-4.907373,"eighty":-2.806332,"marketCap":430695935},{"date":"2024-02-16","current":-2.517378,"twenty":-9.114428,"median":-4.849986,"eighty":-2.790315,"marketCap":478551039},{"date":"2024-02-23","current":-3.232843,"twenty":-9.044173,"median":-4.776239,"eighty":-2.787665,"marketCap":614560281},{"date":"2024-03-01","current":-3.162234,"twenty":-9.011387,"median":-4.733346,"eighty":-2.795615,"marketCap":741961228},{"date":"2024-03-08","current":-2.729051,"twenty":-8.93879,"median":-4.699047,"eighty":-2.787665,"marketCap":640322703},{"date":"2024-03-15","current":-2.393334,"twenty":-8.826382,"median":-4.580215,"eighty":-2.779437,"marketCap":561552847},{"date":"2024-03-22","current":-2.209232,"twenty":-8.791255,"median":-4.524152,"eighty":-2.767887,"marketCap":518356474},{"date":"2024-03-28","current":-2.209232,"twenty":-8.749102,"median":-4.472669,"eighty":-2.760842,"marketCap":518356474},{"date":"2024-04-05","current":-2.26338,"twenty":-8.661036,"median":-4.437996,"eighty":-2.746312,"marketCap":531061289},{"date":"2024-04-12","current":-2.880665,"twenty":-8.612285,"median":-4.40407,"eighty":-2.740398,"marketCap":675896187},{"date":"2024-04-19","current":-2.523289,"twenty":-8.473521,"median":-4.37663,"eighty":-2.729051,"marketCap":592044404},{"date":"2024-04-26","current":-2.390385,"twenty":-8.435978,"median":-4.373545,"eighty":-2.713288,"marketCap":560860924},{"date":"2024-05-03","current":-2.607693,"twenty":-8.343298,"median":-4.308031,"eighty":-2.687454,"marketCap":611848281},{"date":"2024-05-10","current":-2.992192,"twenty":-8.3219,"median":-4.294311,"eighty":-2.687454,"marketCap":683237114},{"date":"2024-05-17","current":-3.103841,"twenty":-8.319809,"median":-4.254687,"eighty":-2.687454,"marketCap":708731037},{"date":"2024-05-24","current":-3.025687,"twenty":-8.307263,"median":-4.253152,"eighty":-2.697369,"marketCap":690885291},{"date":"2024-05-31","current":-2.969862,"twenty":-8.290536,"median":-4.253152,"eighty":-2.702869,"marketCap":678138330},{"date":"2024-06-07","current":-2.768894,"twenty":-8.254974,"median":-4.239432,"eighty":-2.702869,"marketCap":632249270},{"date":"2024-06-14","current":-2.891708,"twenty":-8.249968,"median":-4.234362,"eighty":-2.702869,"marketCap":660292584},{"date":"2024-06-21","current":-2.322298,"twenty":-8.16114,"median":-4.225712,"eighty":-2.684796,"marketCap":530273581},{"date":"2024-06-28","current":-1.540756,"twenty":-8.102755,"median":-4.225015,"eighty":-2.684012,"marketCap":351816126},{"date":"2024-07-05","current":-1.685899,"twenty":-8.085705,"median":-4.184553,"eighty":-2.678934,"marketCap":384958225},{"date":"2024-07-12","current":-1.898032,"twenty":-8.051656,"median":-4.129469,"eighty":-2.657094,"marketCap":433396677},{"date":"2024-07-15","current":-1.909197,"twenty":-8.044209,"median":-4.129265,"eighty":-2.653244,"marketCap":435946069},{"date":"2024-08-02","current":-1.674734,"twenty":-8.037183,"median":-4.122609,"eighty":-2.651573,"marketCap":382408833},{"date":"2024-08-09","current":-1.826341,"twenty":-8.006826,"median":-4.102234,"eighty":-2.638911,"marketCap":384004669},{"date":"2024-08-16","current":-1.528039,"twenty":-7.995377,"median":-4.066555,"eighty":-2.636083,"marketCap":321283906},{"date":"2024-08-23","current":-1.765463,"twenty":-7.98391,"median":-4.033634,"eighty":-2.631614,"marketCap":371204513},{"date":"2024-08-30","current":-1.777639,"twenty":-7.976897,"median":-4.016703,"eighty":-2.61181,"marketCap":373764544},{"date":"2024-09-06","current":-1.558478,"twenty":-7.976897,"median":-3.997437,"eighty":-2.600136,"marketCap":327683984},{"date":"2024-09-13","current":-1.400195,"twenty":-7.950535,"median":-3.965035,"eighty":-2.577437,"marketCap":294403579},{"date":"2024-09-20","current":-1.899395,"twenty":-7.950535,"median":-3.965035,"eighty":-2.570375,"marketCap":399364856},{"date":"2024-09-27","current":-1.850692,"twenty":-7.950535,"median":-3.930735,"eighty":-2.557126,"marketCap":389124731},{"date":"2024-10-04","current":-1.448897,"twenty":-7.935078,"median":-3.892473,"eighty":-2.543877,"marketCap":304643704},{"date":"2024-10-11","current":-1.327141,"twenty":-7.903714,"median":-3.88807,"eighty":-2.530627,"marketCap":279043393},{"date":"2024-10-18","current":-1.436722,"twenty":-7.89199,"median":-3.841772,"eighty":-2.517378,"marketCap":302083673},{"date":"2024-10-25","current":-1.327141,"twenty":-7.88028,"median":-3.830328,"eighty":-2.499039,"marketCap":279043393},{"date":"2024-10-31","current":-1.045032,"twenty":-7.865572,"median":-3.823077,"eighty":-2.47498,"marketCap":219727471},{"date":"2024-11-08","current":-1.531082,"twenty":-7.853532,"median":-3.797329,"eighty":-2.424262,"marketCap":312323797},{"date":"2024-11-15","current":-1.505683,"twenty":-7.846411,"median":-3.786677,"eighty":-2.411954,"marketCap":307142675},{"date":"2024-11-22","current":-1.254644,"twenty":-7.841819,"median":-3.775936,"eighty":-2.392744,"marketCap":255933614},{"date":"2024-11-29","current":-1.293655,"twenty":-7.809622,"median":-3.759997,"eighty":-2.378477,"marketCap":263891402},{"date":"2024-12-06","current":-1.259298,"twenty":-7.769895,"median":-3.714409,"eighty":-2.359862,"marketCap":256882964},{"date":"2024-12-13","current":-1.040564,"twenty":-7.753827,"median":-3.659012,"eighty":-2.350461,"marketCap":212263510},{"date":"2024-12-20","current":-0.877402,"twenty":-7.748728,"median":-3.626782,"eighty":-2.335862,"marketCap":178980413},{"date":"2024-12-27","current":-0.889311,"twenty":-7.730167,"median":-3.608319,"eighty":-2.323428,"marketCap":181409632},{"date":"2025-01-03","current":-0.882877,"twenty":-7.704989,"median":-3.557707,"eighty":-2.2786,"marketCap":180097296},{"date":"2025-01-10","current":-0.933392,"twenty":-7.704643,"median":-3.503182,"eighty":-2.26338,"marketCap":190401751},{"date":"2025-01-17","current":-0.80048,"twenty":-7.694621,"median":-3.473214,"eighty":-2.228646,"marketCap":163289149},{"date":"2025-01-24","current":-0.836716,"twenty":-7.674536,"median":-3.466811,"eighty":-2.211961,"marketCap":170680839},{"date":"2025-01-31","current":-0.835284,"twenty":-7.664509,"median":-3.457401,"eighty":-2.190367,"marketCap":170388677},{"date":"2025-02-07","current":-0.846455,"twenty":-7.663257,"median":-3.446877,"eighty":-2.138425,"marketCap":172667538},{"date":"2025-02-14","current":-0.833565,"twenty":-7.64653,"median":-3.402521,"eighty":-2.079975,"marketCap":170038083},{"date":"2025-02-21","current":-0.94528,"twenty":-7.642348,"median":-3.38156,"eighty":-2.054451,"marketCap":192826692},{"date":"2025-02-28","current":-1.020902,"twenty":-7.637571,"median":-3.343701,"eighty":-1.975864,"marketCap":208252828},{"date":"2025-03-07","current":-1.040381,"twenty":-7.627362,"median":-3.298717,"eighty":-1.933206,"marketCap":212226226},{"date":"2025-03-14","current":-0.521867,"twenty":-7.609389,"median":-3.265577,"eighty":-1.89885,"marketCap":178997262},{"date":"2025-03-21","current":-0.459033,"twenty":-7.587984,"median":-3.241666,"eighty":-1.893187,"marketCap":157445555},{"date":"2025-03-28","current":-0.510936,"twenty":-7.570327,"median":-3.226697,"eighty":-1.876412,"marketCap":175247856},{"date":"2025-04-04","current":-0.400244,"twenty":-7.557107,"median":-3.21693,"eighty":-1.854621,"marketCap":137281423},{"date":"2025-04-11","current":-0.357121,"twenty":-7.549923,"median":-3.198363,"eighty":-1.833647,"marketCap":122490457},{"date":"2025-04-17","current":-0.377865,"twenty":-7.53571,"median":-3.1819,"eighty":-1.804679,"marketCap":129605473},{"date":"2025-04-25","current":-0.401966,"twenty":-7.516892,"median":-3.166597,"eighty":-1.777639,"marketCap":137871881},{"date":"2025-05-02","current":-0.404697,"twenty":-7.507686,"median":-3.164484,"eighty":-1.775075,"marketCap":138808651},{"date":"2025-05-09","current":-0.368533,"twenty":-7.490537,"median":-3.162234,"eighty":-1.765463,"marketCap":126404474},{"date":"2025-05-16","current":-0.354647,"twenty":-7.4795,"median":-3.154836,"eighty":-1.754194,"marketCap":118637096},{"date":"2025-05-23","current":-0.372922,"twenty":-7.470459,"median":-3.154836,"eighty":-1.730229,"marketCap":124750584},{"date":"2025-05-30","current":-0.355548,"twenty":-7.461092,"median":-3.125893,"eighty":-1.710392,"marketCap":118938486},{"date":"2025-06-06","current":-0.507293,"twenty":-7.420321,"median":-3.116245,"eighty":-1.685899,"marketCap":169700573},{"date":"2025-06-13","current":-0.431155,"twenty":-7.403982,"median":-3.113599,"eighty":-1.670898,"marketCap":144230679},{"date":"2025-06-20","current":-0.424072,"twenty":-7.391436,"median":-3.092676,"eighty":-1.665525,"marketCap":141861387},{"date":"2025-06-27","current":-0.403709,"twenty":-7.391436,"median":-3.084406,"eighty":-1.652405,"marketCap":135049671},{"date":"2025-07-03","current":-0.428941,"twenty":-7.389083,"median":-3.074,"eighty":-1.61891,"marketCap":143490275},{"date":"2025-07-11","current":-0.432483,"twenty":-7.365757,"median":-3.059181,"eighty":-1.558478,"marketCap":144674922},{"date":"2025-07-18","current":-0.421416,"twenty":-7.354708,"median":-3.044181,"eighty":-1.530473,"marketCap":140972902},{"date":"2025-07-25","current":-0.460813,"twenty":-7.344,"median":-3.026095,"eighty":-1.517452,"marketCap":154152091},{"date":"2025-08-01","current":-0.523591,"twenty":-7.306207,"median":-3.009843,"eighty":-1.505683,"marketCap":175152551},{"date":"2025-08-08","current":-0.52307,"twenty":-7.288981,"median":-2.992192,"eighty":-1.485424,"marketCap":174978334},{"date":"2025-08-15","current":-0.623761,"twenty":-7.261799,"median":-2.985202,"eighty":-1.446462,"marketCap":206712533},{"date":"2025-08-22","current":-0.617384,"twenty":-7.230435,"median":-2.981027,"eighty":-1.424546,"marketCap":204599301}],"updateTime":1756112533595},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LYEL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2562302243","title":"Lyell Immunopharma (LYEL) Receives a Sell from Bank of America Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2562302243","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562302243?lang=en_us&edition=fundamental","pubTime":"2025-08-25 18:35","pubTimestamp":1756118148,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Jason Zemansky reiterated a Sell rating on Lyell Immunopharma today and set a price target of $12.00. The compan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lyell-immunopharma-lyel-receives-a-sell-from-bank-of-america-securities-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lyell-immunopharma-lyel-receives-a-sell-from-bank-of-america-securities-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B7SZLL34.SGD","LU1069347547.HKD","LU0648000940.SGD","LU0868494617.USD","LU1201861249.SGD","LU1162221912.USD","BK4585","LU0130103400.USD","LU0314106906.USD","LU1363072403.SGD","LU0321505868.SGD","LYEL","LU0128525689.USD","LU0477156797.USD","LU1280957306.USD","LU2129689605.HKD","LU1883839398.USD","LU1035773651.USD","LU0106831901.USD","LU0256863902.USD","IE0002270589.USD","LU0971096721.USD","BK4539","LU0648001328.SGD","LU1074936037.SGD","LU0320765489.SGD","IE00BFXG1179.USD","BK4559","LU0306807586.USD","LU0310800965.SGD","LU1880398471.USD","IE00B19Z3B42.SGD","LU0149725797.USD","LU1791807156.HKD","LU0208291251.USD","LU0234572021.USD","LU0320765646.SGD","LU1718418525.SGD","LU1366192091.USD","BAC","BK4553","LU0640476718.USD","IE00B19Z3581.USD","IE00BBT3K403.USD","BK4588","LU0683600562.USD","LU2129689431.USD","BK4504","LU0203345920.USD","LU1201861165.SGD"],"gpt_icon":0},{"id":"2561400532","title":"Lyell Immunopharma's Chief Scientific Officer Gary K. Lee Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2561400532","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561400532?lang=en_us&edition=fundamental","pubTime":"2025-08-23 04:03","pubTimestamp":1755892981,"startTime":"0","endTime":"0","summary":"Gary K. Lee, the Chief Scientific Officer of Lyell Immunopharma Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 22, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250822:nNDL9yyrzR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LYEL","BK4505","BK4539"],"gpt_icon":0},{"id":"2560906074","title":"Analysts Offer Insights on Healthcare Companies: Catalyst Pharma (CPRX), BioAge Labs, Inc. (BIOA) and Lyell Immunopharma (LYEL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2560906074","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560906074?lang=en_us&edition=fundamental","pubTime":"2025-08-18 18:40","pubTimestamp":1755513606,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Catalyst Pharma (CPRX – Research Report), BioAge L...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-catalyst-pharma-cprx-bioage-labs-inc-bioa-and-lyell-immunopharma-lyel-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-catalyst-pharma-cprx-bioage-labs-inc-bioa-and-lyell-immunopharma-lyel-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LYEL","BK4539","CPRX","BK4505","BK4007","BIOA","HCSG","IE0034390439.USD","IE00B19Z6F94.USD","BK4139"],"gpt_icon":0},{"id":"2559371938","title":"CFO Charles W. Newton Reports Disposal of Lyell Immunopharma Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2559371938","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559371938?lang=en_us&edition=fundamental","pubTime":"2025-08-14 09:06","pubTimestamp":1755133591,"startTime":"0","endTime":"0","summary":"Charles W. Newton, the Chief Financial Officer of Lyell Immunopharma Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 13, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDLZDvBD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LYEL","BK4539","BK4505"],"gpt_icon":0},{"id":"2559600689","title":"Lyell Immunopharma trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2559600689","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559600689?lang=en_us&edition=fundamental","pubTime":"2025-08-13 21:55","pubTimestamp":1755093320,"startTime":"0","endTime":"0","summary":"09:54 EDT Lyell Immunopharma (LYEL) trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lyell-immunopharma-trading-resumes-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lyell-immunopharma-trading-resumes-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LYEL","BK4539","BK4139","BK4505"],"gpt_icon":0},{"id":"2559651621","title":"Lyell Immunopharma Reports Q2 2025 Net Loss of $42.7M, Decrease from $45.8M in Q2 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2559651621","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559651621?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:09","pubTimestamp":1755029386,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via GlobeNewswire  on August 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nNDL1PJ44P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4139","IE00B3QW5Z07.USD","LU2210149790.SGD","LYEL","BK4588","BK4505","LU2210150020.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","LU2095319765.USD","BK4539","IE00B64PRP62.GBP","NDAQ","LU0314104364.USD","BK4585"],"gpt_icon":0},{"id":"2559249196","title":"Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2559249196","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559249196?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:05","pubTimestamp":1755029100,"startTime":"0","endTime":"0","summary":"Presented positive new clinical data demonstrating high rates of durable complete responses from the Phase 1/2 trial of LYL314 for the treatment of aggressive large B-cell lymphomaInitiated the PiNACL","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/12/3132110/0/en/Lyell-Immunopharma-Reports-Business-Highlights-and-Financial-Results-for-the-Second-Quarter-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","CRS","IE0031619046.USD","IE00B7SZL793.SGD","BK4230","CAR","LU2065731478.USD","BK4539","LYEL","IE00B19Z4B17.USD","LU0963586101.USD","BK4505","IE00B66KJ199.SGD","BK4006","BK4139"],"gpt_icon":0},{"id":"2557317049","title":"Lyell Immunopharma Inc  expected to post a loss of $3.58 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2557317049","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557317049?lang=en_us&edition=fundamental","pubTime":"2025-08-06 06:31","pubTimestamp":1754433081,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma Inc  expected to post a loss of $3.58 a share - Earnings Preview Lyell Immunopharma Inc LYEL.OQ LYEL.O is expected to  show a fall in quarterly revenue when it reports  results on A","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nL8N3TX3TD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYEL"],"gpt_icon":0},{"id":"2555098414","title":"Lyell Immunopharma Inc. Files Initial Statement of Beneficial Ownership for ARCH Venture Fund XIII, L.P","url":"https://stock-news.laohu8.com/highlight/detail?id=2555098414","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555098414?lang=en_us&edition=fundamental","pubTime":"2025-07-30 09:24","pubTimestamp":1753838682,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma Inc. has filed an initial statement of beneficial ownership, identifying ARCH Venture Fund XIII, L.P. as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250730:nNDL17rRbm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYEL","BK4139","BK4505","BK4539"],"gpt_icon":0},{"id":"2554762291","title":"Lyell Immunopharma Initiates Phase 3 Clinical Trial for LYL314 in Relapsed or Refractory Large B-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2554762291","media":"Reuters","labels":["shareholding","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554762291?lang=en_us&edition=fundamental","pubTime":"2025-07-25 20:06","pubTimestamp":1753445192,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma, Inc. has announced the initiation of two pivotal-stage clinical trials for its product candidate LYL314. The trials will focus on patients with large B-cell lymphoma  who have relapsed or are refractory to two or more lines of prior therapy. The company plans to submit a Biologics License Application for LYL314 later in 2027, following the expected data from the LYL314 PiNACLE pivotal trial. Additionally, Lyell is set to conduct a Phase 3 randomized controlled trial for LYL314 in the second-line setting for relapsed or refractory LBCL patients. Furthermore, the company intends to begin a clinical trial evaluating a new internally-developed CAR T-cell therapy targeting an undisclosed solid tumor. Results from these trials are anticipated in the future, with a clinical trial data update from LYL314 expected by the end of this year.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nNDL8lHkc7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","BK4539","LYEL"],"gpt_icon":0},{"id":"2554762950","title":"Lyell Immunopharma Announces Up to $100 Million Equity Private Placement to Fund Clinical Trials and Corporate Initiatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2554762950","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554762950?lang=en_us&edition=fundamental","pubTime":"2025-07-25 20:00","pubTimestamp":1753444820,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma Inc., a clinical-stage company focused on advancing next-generation CAR T-cell therapies for cancer treatment, announced a securities purchase agreement for a private placement with institutional and accredited investors, potentially raising up to $100 million. The initial closing is expected to yield approximately $50 million from the sale of common stock at $13.32 per share. The funds will support pivotal-stage clinical trials of LYL314 and other corporate purposes, with expectations to sustain financial needs into mid-2027. This includes funding through significant milestones such as a clinical trial data update from LYL314, the initiation of a Phase 3 trial for relapsed or refractory large B-cell lymphoma, and a trial for a new CAR T-cell therapy targeting an undisclosed solid tumor. Investors are provided with resale registration rights for the common stock shares issued in this financing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nNDL9klSct:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4112","IE00B64PRP62.GBP","LU2210149790.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","BK4585","BK4505","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2210150020.SGD","LYEL","BK4539","BK4588","NDAQ"],"gpt_icon":0},{"id":"2554623987","title":"Lyell Immunopharma Announces up to $100 Million Equity Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2554623987","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554623987?lang=en_us&edition=fundamental","pubTime":"2025-07-25 20:00","pubTimestamp":1753444800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nTUA8YVSRV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","LYEL","BK4505","BK4139"],"gpt_icon":0},{"id":"2554611762","title":"Lyell Immunopharma Inc - Proceeds to Fund Two Pivotal-Stage Trials of Lyl314","url":"https://stock-news.laohu8.com/highlight/detail?id=2554611762","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554611762?lang=en_us&edition=fundamental","pubTime":"2025-07-25 20:00","pubTimestamp":1753444800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nTUA8YVSRV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LYEL","BK4139","BK4539","BK4505"],"gpt_icon":0},{"id":"2552406415","title":"Lyell Immunopharma files to sell 625,000 shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2552406415","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552406415?lang=en_us&edition=fundamental","pubTime":"2025-07-19 10:25","pubTimestamp":1752891953,"startTime":"0","endTime":"0","summary":"22:21 EDT Lyell Immunopharma (LYEL) files to sell 625,000 shares of common stock for holders Published first on TheFly – the ultimate source for re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lyell-immunopharma-files-to-sell-625000-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lyell-immunopharma-files-to-sell-625000-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4505","LYEL","BK4139"],"gpt_icon":0},{"id":"2546759304","title":"Lyell Immunopharma Inc. Completes Issuance of 625,000 Equity Milestone Shares Following ImmPACT Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2546759304","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546759304?lang=en_us&edition=fundamental","pubTime":"2025-06-27 04:07","pubTimestamp":1750968467,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma Inc. has issued 625,000 shares of its common stock to the securityholders of ImmPACT Bio USA Inc. following the achievement of certain clinical milestones. The transaction was conducted under a private placement and was exempt from registration under the Securities Act. The document does not provide the price of these shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 26, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nNDL5N4KwK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","LYEL","BK4505"],"gpt_icon":0},{"id":"2545289781","title":"Lyell Immunopharma Is Maintained at Neutral by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2545289781","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545289781?lang=en_us&edition=fundamental","pubTime":"2025-06-24 19:12","pubTimestamp":1750763520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LYEL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 24, 2025 07:12 ET (11:12 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYEL"],"gpt_icon":0},{"id":"2545440287","title":"Lyell Immunopharma Inc. to Participate in H.C. Wainwright \"HCW@Home\" Series for Discussion on Innovative CAR T-Cell Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2545440287","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545440287?lang=en_us&edition=fundamental","pubTime":"2025-06-24 05:00","pubTimestamp":1750712418,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma Inc. to Participate in H.C. Wainwright \"HCW@Home\" Series for Discussion on Innovative CAR T-Cell Therapies. Lyell Immunopharma, Inc., a clinical-stage company focused on advancing CAR T-cell therapies for cancer treatment, will participate in the H.C. Wainwright \"HCW@Home\" Series on June 25, 2025. During the event, Lyell's senior management, including President and CEO Lynn Seely and CFO Charlie Newton, will discuss positive new clinical data on LYL314, a dual-targeting CAR T-cell product candidate for large B-cell lymphoma.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via GlobeNewswire  on June 23, 2025, and is solely responsib","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nNDL2BmbPj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYEL","LU2210149790.SGD","NDAQ","IE00B64PRP62.GBP","BK4539","LU2095319765.USD","BK4505","BK4139","LU2210150020.SGD","BK4112","BK4588","BK4585","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2545172388","title":"Morgan Stanley Sticks to Its Hold Rating for Lyell Immunopharma (LYEL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2545172388","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545172388?lang=en_us&edition=fundamental","pubTime":"2025-06-21 01:45","pubTimestamp":1750441559,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Lyell Immunopharma (LYEL – Research Report) on June 16. The company’s shares open...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-its-hold-rating-for-lyell-immunopharma-lyel-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-its-hold-rating-for-lyell-immunopharma-lyel-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LYEL"],"gpt_icon":0},{"id":"2544199908","title":"BUZZ-U.S. STOCKS ON THE MOVE-Red Cat, Nvidia Corp, Redwire","url":"https://stock-news.laohu8.com/highlight/detail?id=2544199908","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544199908?lang=en_us&edition=fundamental","pubTime":"2025-06-18 00:02","pubTimestamp":1750176150,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Red Cat, Nvidia Corp, RedwireEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: http","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nL6N3SK0RJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEN","NVD2.UK","NVIW.SI","NVAX","ET","FVR","NVD","RUN","NVDY","CTRI","JBL","NVDX","RCAT","NVDD","LNG","3NVD.UK","GALT","LYEL","TMUS","LU1037948541.HKD","NVDU","NVD3.UK","LU2347655156.SGD","2NVD.UK","NVDA","JBLU","FDX","SGRY","DVN","ARRY","DYN","NVDS","WMB","EQT","RDW","WLY","IE00BKPKM429.USD","VERV","EOG","LU1951200564.SGD","LU0130102774.USD","SHLS","MMYT","CVX","SNVD.UK","NVDS.UK"],"gpt_icon":1},{"id":"2544648779","title":"BUZZ-U.S. STOCKS ON THE MOVE-Verve Therapeutics, Lyell Immunopharma, Energy companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2544648779","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544648779?lang=en_us&edition=fundamental","pubTime":"2025-06-17 19:38","pubTimestamp":1750160338,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Verve Therapeutics, Lyell Immunopharma, Energy companiesEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nL6N3SK0KA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVN","LU0312595415.SGD","LU1074936037.SGD","TMUS","LU0128525929.USD","BK4516","LU0070302665.USD","SG9999002521.SGD","ARRY","LYEL","IE00BGHQF524.EUR","BK4570","LU2361044949.HKD","LU1983260115.SGD","LU2125154778.USD","FSLR","SHLS","LU0792757196.USD","LU0154245756.USD","LU1150488218.USD","LU1621768115.EUR","LU1582987324.SGD","LU0345780950.USD","LU0823414478.USD","SG9999014567.USD","VERV","LU1066051498.USD","LU0942090050.USD","LU2272731782.SGD","LU2361044865.SGD","CVX","BK4533","LU0310800379.SGD","LU2098885051.SGD","LU0098860793.USD","LU1582986359.USD","LU0456854461.SGD","LU0868494617.USD","LU0889566641.SGD","SG9999001440.SGD","LU0122376428.USD","LU0234572021.USD","LU2237438978.USD","LU0985489474.SGD","LU2264538146.SGD","LU2592432038.USD","IE00B1XK9C88.USD","RUN"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":49,"code":"91000000","status":"200"}]}}